University College London

University College London (UCL) is a core academic partner of the COG-UK consortium. The COG-UK Hospital Onset COVID-19 Infection (HOCI) study is led by UCL — which is investigating how integrating rapid, real-time COVID-19 genomic sequencing can impact decision-making by infection control teams to prevent the spread of the SARS-CoV-2 virus in NHS hospitals. The team have been working in joint partnership with Virology at Imperial College Healthcare NHS Trust, Dr David Muir and Dr Paul Rendell.


Leading the sequencing initiative at UCL are: